Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	32.85 %	35.31 %	-	-	-
Y / Y Net Income Change	14.52 %	-27.15 %	-	-	-
Return On Equity	18.94 %	21.97 %	40.8 %	-	-

MDXG all Ratios >> Back to MDXG Management Effectiveness >> See Quarterly MDXG Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2025) ROE detoriated to 18.94 %, despite net income growth.

Financial Statements
Mimedx Group Inc 's Equity	$ 257 Millions	Annual MDXG's Balance sheet
Mimedx Group Inc 's Annual Income	$ 49 Millions	Annual MDXG's Income Statement
Where are MDXG's Income coming from?		Visit MDXG's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.